August 19, 2026
Who decides in the EU?
Out of five Croatians in Brussels, roughly one in five Croatians decided who would speak for the other four in…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: EU
November 27, 2018
Sandoz gets marketing pass in EU for Ziextenzo, for helping treat cancer with cytotoxic chemotherapy in adults
Novartis’ Sandoz, received on Tuesday from the European Commission (EC) the marketing authorization for biosimilar Ziextenzo (pegfilgrastim), which is indicated to reduce the…
April 10, 2017
Twenty-one countries vie to host EU drug agency after Brexit
The European Medicines Agency has had expressions of interest to host the London-based regulator from 21 of the 27 countries that will form the European Union once Britain leaves, revealing rivalry from Amsterdam to Zagreb for a prized institution.
February 24, 2017
Novartis makes first step in making Tafinlar + Mekinist available for certain NSCLC patients
Novartis could get first targeted treatment for patients with BRAF non-small cell lung cancer if European Medicines Agency (EMA) approves Tafinlar+Mikinist combination.
February 22, 2017
“Alarming” superbugs a risk to people, animals and food, EU warns
Superbug bacteria found in people, animals and food across the European Union pose an “alarming” threat to public and animal health having evolved to resist widely used antibiotics, disease and safety experts warned on Wednesday.
February 21, 2017
Amgen gets more options for using Repatha, EU approves single-dosing
Amgen on Tuesday got clearance from the European Commission (EC) for a new single-dose delivery option for its Repatha cardiovascular drug.
January 30, 2017
Drugmaker Novo Nordisk bets $145 million on post-Brexit UK science
Novo Nordisk, the world’s top maker of diabetes drugs, is investing 115 million pounds ($145 million) in a new research center in Britain, undeterred by Brexit.
January 28, 2017
Swedish Vicore Pharma’s IPF candidate C21 becomes orphan drug in US
Vicore Pharma’s C21 drug for treating idiopathic pulmonary fibrosis (IPF) has officially became an orphan drug in the USA.
December 12, 2016
Herantis gets funds for its Parkinson’s disease study
The research and innovation program of the European Union, Horizon 2020, has awarded a grant of approximately €6.0 million for…
September 25, 2015
CHMP reccomends Bayer’s Eye medicine for approval in EU
The European Committee for Medicinal Products for Human Use (CHMP) has recommended Bayer’s aflibercept solution for injection into the eye…